Merck & Co Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, everybody. I'm Chris Schott at JPMorgan. And it's my pleasure to be introducing Merck today as we wrap up day 1 of the 40th Annual JPMorgan Healthcare Conference.
From the company, we have Rob Davis, the company's CEO; as well as Dean Li, President of Merck Research Labs. So Rob and Dean, Happy New Year. Great speaking with you today, and I look forward to the presentation.
Before I turn it over to Rob, I did want to mention, if anyone wants to ask a question during the Q&A portion of this, feel free to submit that through the Ask a Question button, and I'll work those into my Q&A as we go through.
With that, let me turn the call over to Rob to run through the presentation.
Well, great. Thanks, Chris, and good evening, everyone. I'm excited to be here with Dean to share with you our thoughts on why we're so confident about our ability to deliver short
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
